Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$897,222
+$22,729 QoQ
Shares Held
5,725
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#660
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Radnor Capital Management, LLC holds $105,731,738 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
518,900 | $66,678,650 | |
| 2 | LLY |
ELI LILLY & Co
|
9,442 | $11,325,019 | |
| 3 | JNJ |
Johnson & Johnson
|
42,628 | $10,826,233 | |
| 4 | ABBV |
AbbVie Inc.
|
28,539 | $7,181,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,233 | $4,565,405 | |
| 6 | AMGN |
Amgen Inc
|
6,596 | $2,388,543 | |
| 7 | PFE |
Pfizer Inc
|
77,621 | $1,869,113 | |
| 8 | NVS |
Novartis AG
This page
|
5,725 | $897,222 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $897,222 | 5,725 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $874,493 | 5,725 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $789,305 | 5,725 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $734,174 | 5,725 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $692,782 | 5,725 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $607,566 | 5,450 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $530,339 | 5,450 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $750,505 | 6,525 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $630,775 | 5,925 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $573,125 | 5,925 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $628,538 | 6,225 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $649,357 | 6,375 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $673,574 | 6,675 | Shares | Sole | 2023-07-07 | |
| 2022-12-31 | $619,164 | 6,825 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $558,293 | 7,345 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $595,513 | 7,045 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $618,198 | 7,045 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $690,575 | 7,895 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $778,954 | 9,525 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $869,061 | 9,525 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $814,197 | 9,525 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $960,825 | 10,175 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $880,470 | 10,125 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $901,785 | 10,325 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $851,296 | 10,325 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||